Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer.
Sven Heiko LoosenJustus HalpaapSimon LabuhnJan BednarschPatrick H AlizaiAnjali A RoethSven A LangMihael VucurJakob Nikolas KatherWolfram T KnoefelTom F UlmerUlf P NeumannChristoph RoderburgTom LueddePublished in: Cancers (2022)
GP73 represents a previously unrecognized biomarker in the patients with resectable BTC that identifies patients with an impaired postoperative outcome. If larger clinical trials confirmed these findings, measurement of GP73 serum levels might become a novel tool in the challenging preoperative stratification process of patients with resectable BTC.